Stay updated with breaking news from Xlife Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to
29.12.2023 - Xlife Sciences AG / Key word(s): Mergers & Acquisitions/Takeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29-Dec-2023 / 17:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely ... Seite 1
Xlife Sciences AG / Key word(s): Letter of Intent/PartnershipXlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases 20.12.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) and Quant Biomar...
Xlife Sciences AG / Key word: Regulatory Approval Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration 18-Dec-2023 / 07:00 CET/CEST Release of an...
Xlife Sciences AG / Key word(s): Disposal/Investment Successful exit of portfolio company and major invest in AI and digital health in ...